文献速递主动脉疾病内脏/肾动脉与血管畸形

腹主动脉瘤合并马蹄肾患者的血管腔内动脉瘤修复:系统综述

EVAR in Patients With Abdominal Aortic Aneurysm and Horseshoe Kidney: A Systematic Review.
PubMed 文献 · J Endovasc Ther · 2021-11-26

本系统综述纳入30项研究共50例腹主动脉瘤合并马蹄肾并择期行血管腔内动脉瘤修复的患者,男性占88%(n=44),中位年龄70岁,中位瘤径6.0 cm,中位手术时间84分钟,总体并发症率14%(n=7),中位随访19个月。综述提出马蹄肾血管A+B+C分型,认为血管腔内修复是低并发症率的优良选择。

要点

  • 50例腹主动脉瘤合并马蹄肾患者择期行血管腔内修复,总体并发症率14%(n=7)。
  • 最常用移植物为Zenith(40%,n=20),其次为Endurant(14%,n=7)。
  • 吸烟者中位手术时间84分钟 vs 非吸烟者118分钟(p=0.048)。

核心结论

  • 本系统综述认为血管腔内动脉瘤修复是治疗马蹄肾合并腹主动脉瘤患者低并发症率的优良选择。
  • 综述提出并实施用于马蹄肾血管分组的A+B+C分类。

研究设计与样本

  • 系统综述检索PubMed、Google Scholar、Scopus及美国国家生物技术信息中心数据库,检索词包括腹主动脉瘤、AAA、EVAR、血管腔内动脉瘤修复和马蹄肾。
  • 纳入标准为所有已发表的腹主动脉瘤合并马蹄肾择期行血管腔内治疗的患者资料。
  • 排除接受杂交或开放修复的患者以及腹主动脉瘤破裂的患者。
  • 共纳入来自30项研究的50例患者进行分析。
  • 统计分析使用SPSS Statistics版本25(IBM Corp,阿蒙克,纽约)软件。

主要发现

  • 男性占88%(n=44),中位年龄70岁(范围47-86岁),中位瘤径6.0 cm(范围4.0-10.3 cm)。
  • 血管腔内修复中位手术时间84分钟(范围40-332分钟)。
  • 最常用移植物为Zenith(40%,n=20),其次为Endurant(14%,n=7)。
  • 总体并发症率14%(n=7),中位随访19个月(范围1-108个月)。
  • 吸烟者中位手术时间84分钟 vs 非吸烟者118分钟(p=0.048);瘤径与手术时间在单变量线性回归中呈显著系数关联;调整合并症与瘤径后,既往慢性肾病显著增加肾梗死比值比。

关键数值与推荐

  • 纳入50例来自30项研究的腹主动脉瘤合并马蹄肾择期血管腔内修复患者。
  • 总体并发症率14%(n=7)。
  • 吸烟者中位手术时间84分钟 vs 非吸烟者118分钟(p=0.048)。
  • 瘤径与手术时间在单变量线性回归模型中呈显著系数关联。
  • 调整合并症与瘤径后,既往慢性肾病显著增加肾梗死比值比。

临床怎么用

  • 本系统综述提示血管腔内动脉瘤修复是马蹄肾合并腹主动脉瘤患者低并发症率的优良选择。
  • 作者实施A+B+C分类用于马蹄肾血管分组描述。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: A systematic review of all patients that have been reported in the literature with abdominal aortic aneurysm (AAA) concomitant with horseshoe kidney (HSK) treated electively by endovascular aneurysm repair (EVAR) is presented. A new grouping system for describing HSK vasculature is implemented. MATERIALS AND METHODS: We searched for published manuscripts using the Medical Subject Headings terms "abdominal aortic aneurysm," "AAA," "EVAR," "endovascular aneurysm repair," and "horseshoe kidney" in PubMed, Google Scholar, Scopus, and National Center for Biotechnology Information databases. Inclusion criteria include all published material of patients with AAA with HSK treated electively by an endovascular approach. We excluded patients who were treated by a hybrid or open repair or patients with ruptured AAA. Statistical analysis was carried out using SPSS Statistics version 25 (IBM Corp, Armonk, New York) software. RESULTS: A total of 50 patients from 30 studies were included for analysis. Males made up 88% (n=44) of the population. The median age for this cohort was 70 years (range: 47-86 years). Median aneurysmal diameter was 6.0 cm (range: 4.0-10.3 cm). The median operative time for endovascular repair was 84 minutes (range: 40-332 minutes). The most common graft used was Zenith, used in 40% (n=20) of the cases, followed by Endurant in 14% (n=7). The overall complication rate was 14% (n=7). The median follow-up was 19 months (range: 1-108 months). While comorbidities did not appear to impact outcomes significantly, median operative times for smokers were higher than those in nonsmokers, 84 versus 118 minutes, respectively (p=0.048). Univariate linear regression modeling of aneurysmal size with age, operative time, and length of stay revealed a significant coefficient association between aneurysmal size and operative times. After adjusting for comorbidities and aneurysmal size, prior history of chronic kidney disease significantly increased odds for renal infarction. CONCLUSION: This review presents the most complete data set possible of patients with concomitant HSK and AAA treated by an endovascular approach. Furthermore, the A + B + C classification for grouping the HSK vasculature is implemented. This systematic review suggests EVAR to be an excellent option with low complication rates for the treatment of AAA in patients with HSK.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Gonzalez-Urquijo M, Padilla-Armendariz DP, Hinojosa-Gonzalez DE, et al. EVAR in Patients With Abdominal Aortic Aneurysm and Horseshoe Kidney: A Systematic Review. J Endovasc Ther. 2021. PMID: 34836459. doi:10.1177/15266028211059447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。